Sexually Transmitted Infections in Migrant Women

March 24, 2026 updated by: Emine Aksut Akcay, Kahramanmaras Sutcu Imam University

The Effect of Sexual Health Self-Efficacy and Reproductive Autonomy in Migrant Women Through Sexual Transmission Infections A Randomized Controlled Study

The main objective of this study is to evaluate the effect of structured sexual health education for immigrant women on their levels of sexual health self-efficacy and reproductive autonomy using a randomized controlled design.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

Sexuality is a fundamental aspect of human life that encompasses biological, psychological, and social dimensions and is shaped by individuals' personality traits, life experiences, and social conditions. Sexual satisfaction and adjustment are related not only to physical processes but also to psychological well-being and interpersonal relationships. In this context, sexual self-efficacy-defined as an individual's belief in their ability to manage emotions and behaviors in sexual situations-plays an important role, while reproductive autonomy refers to the ability to freely decide whether and when to have children. Migrant women may be more vulnerable in these areas due to various social and structural barriers; therefore, efforts aimed at strengthening sexual health self-efficacy and reproductive autonomy are considered important.

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • To be eligible, applicants must:
  • Be 18 years of age or older,
  • Have immigrant status and reside in Turkey,
  • Be one of the women who applied to or benefited from the services of the

Exclusion Criteria:

  • Being under 18 years of age,
  • Refusal to give informed consent for participation in the study,
  • Having a serious cognitive impairment or psychiatric condition that may prevent regular participation in the training and data collection process,
  • Having a severe language barrier that prevents communication during the study process and that cannot be overcome with translation or written materials,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: experimental group
Application Description: The experimental group will receive education on sexually transmitted diseases and will be administered reproductive autonomy and sexual self-efficacy scales.
Behavioral: education
Training Sessions and Topics Session 1: Sexually Transmitted Infections and Women's Health Definition and types of STIs Symptoms and asymptomatic courses in women Relationship of STIs with reproductive health and HIV risk Transmission routes and the importance of testing Session 2: Sexual Health Self-Efficacy and Protective Behaviors The concept of sexual health self-efficacy Protection methods and correct condom use Seeking healthcare and requesting testing Communication with healthcare professionals Session 3: Reproductive Autonomy, Communication, and Rights Reproductive autonomy and decision-making Communication with partners and setting boundaries Confidentiality and consent in healthcare Coping with stigma
No Intervention: No Intervention: Control Group
No intervention will be made in the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary endpoint will be the difference in mean knowledge scores between baseline (pre-intervention) and post-intervention assessments.
Time Frame: Pre-intervention (week 0), post-intervention (week 8), and 3-month follow-up.
  1. Level of Knowledge Regarding Sexually Transmitted Infections (STIs): Participants' level of knowledge regarding STIs will be assessed using knowledge questions included in a data collection form prepared by the researchers. The measurement tool is a structured questionnaire. The unit of measurement is the number of correct answers, and the total score obtained indicates the level of knowledge about STIs. Higher scores indicate a higher level of knowledge.
  2. Level of Sexual Self-Efficacy: Participants' level of sexual self-efficacy will be assessed using the Sexual Self-Efficacy Scale (SSES), developed by Humphreys and Kennett (2010) and adapted into Turkish by Çelik (2012). The scale is an 8-point Likert-type scale consisting of 5 items. The unit of measurement is the total scale score, and the score range is 5-40. Higher scores indicate a higher level of sexual self-efficacy.
Pre-intervention (week 0), post-intervention (week 8), and 3-month follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary endpoint will be the change in the mean RAS score between baseline (pre-intervention) and post-intervention assessments.
Time Frame: Immediately after the intervention is completed.
1. Level of Reproductive Autonomy: Participants' level of reproductive autonomy will be assessed using the scale developed by Upadhyay et al. The Reproductive Autonomy Scale (RAS), developed by (2014) and validated and proven reliable in Turkish by Dursun and Gözüyeşil (2023), will be used for evaluation. The scale consists of 14 items and three sub-dimensions (Decision Making, Coercion Avoidance, Communication). The unit of measurement is the scale score, which is calculated as the average score obtained by dividing the total score by the number of items. Higher scores indicate higher reproductive autonomy.
Immediately after the intervention is completed.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Kahramanmaras Sutcu Imam University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Sadock, V. A. (1989). Psychosexual dysfunctions and treatment. In H. I. Kaplan & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry (5th ed.). Baltimore, MD: Williams & Wilkins.
  • Reissing, E. D., Laliberté, G. M., & Davis, H. J. (2005). Young women's sexual adjustment: The role of sexual self-schema, sexual self-efficacy, sexual aversion and body attitudes. The Canadian Journal of Human Sexuality, 14(3-4).
  • Grace, K. T., & Anderson, J. C. (2018). Reproductive coercion: A systematic review. Trauma, Violence, & Abuse, 19(4), 371-390. doi:10.1177/1524838016663935
  • Eysenck, H. J. (1971). Hysterical personality and sexual adjustment, attitudes and behavior. Journal of Sex Research, 7, 274-281.
  • Creti, L., & Libman, E. (1989). Cognitions and sexual expression in the aging. Journal of Sex & Marital Therapy, 15, 83-101.
  • Bailes, S., Creti, L., Fichten, C. S., Libman, E., Brender, W., & Amsel, R. (1998). Sexual self-efficacy scale for female functioning. In C. M. Davis, W. L. Yarber, R. Bauserman, G. Schreer, & S. L. Davis (Eds.), Handbook of sexuality-related measures (pp. 531-534). London, England: Sage.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Actual)

March 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

March 9, 2026

First Submitted That Met QC Criteria

March 12, 2026

First Posted (Actual)

March 13, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KahramanmarasSIUniversity (Registry Identifier: KahramanmarasSIUniversity)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

I do not approve of sharing ipd

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sexually Transmitted Disease

Clinical Trials on education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe